Robert Gershon - Bovie Medical CEO and Director
CEO
Mr. Robert L. Gershon is an Chief Executive Officer, Director of the Company. He was the Company Chief Executive Officer and Director since December 2013, He has over 28 years of healthcare industry experience. On the operations side he ran the largest sales and marketing business at Covidien. With over 1B in PL responsibility he consistently led an organization of over 600 people to doubledigit revenue growth outpacing market category growth and capturing significant market share points during challenging healthcare economic conditions. He also was VP of sales and marketing at Henry Schein and earlier in his career spent over 13 years as a healthcare consultant for Booz Allen Hamilton, KPMG and two boutique consultancies where his practice focused on strategic planning, business development and mergers and acquisitions since 2013.
| Age | 49 |
| Tenure | 11 years |
| Professional Marks | MBA |
| Phone | 727 384 2323 |
| Web | http://www.boviemedical.com |
Bovie Medical Management Efficiency
The company has Return on Asset of (1.34) % which means that on every $100 spent on assets, it lost $1.34. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.91) %, meaning that it generated no profit with money invested by stockholders. Bovie Medical's management efficiency ratios could be used to measure how well Bovie Medical manages its routine affairs as well as how well it operates its assets and liabilities.The company has 140 K in debt with debt to equity (D/E) ratio of 0.1, which may show that the company is not taking advantage of profits from borrowing. Bovie Medical has a current ratio of 4.83, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Debt can assist Bovie Medical until it has trouble settling it off, either with new capital or with free cash flow. So, Bovie Medical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Bovie Medical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Bovie to invest in growth at high rates of return. When we think about Bovie Medical's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Found 7 records | CEO Age | ||
| Masamichi Terabatake | Japan Tobacco ADR | 58 | |
| Marcie Barber | Juniata Valley Financial | 64 | |
| Hikmet Ersek | Western Union Co | 60 | |
| Mitsuomi Koizumi | Japan Tobacco ADR | 59 | |
| Edward Bernstein | Westrock Coffee | 63 | |
| Michael Blodnick | Glacier Bancorp | 63 | |
| Devin McGranahan | Western Union Co | 54 | |
Management Performance
| Return On Equity | -0.91 | |||
| Return On Asset | -1.34 |
Bovie Medical Leadership Team
Elected by the shareholders, the Bovie Medical's board of directors comprises two types of representatives: Bovie Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bovie. The board's role is to monitor Bovie Medical's management team and ensure that shareholders' interests are well served. Bovie Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bovie Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Moshe Citronowicz, Sr. VP | ||
| Michael Geraghty, Independent Director | ||
| John Saron, President Chief Sales and Marketing Officer, Director | ||
| Robert Gershon, CEO and Director | ||
| Andrew Makrides, Executive Chairman of the Board | ||
| Charles Orsatti, Director | ||
| John McCarthy, Chief Commercialization Officer | ||
| Jack McCarthy, Chief Commercialization Officer | ||
| John Andres, Independent Director | ||
| Scott Davidson, Independent Director | ||
| Craig Swandal, Director | ||
| Charles Goodwin, CEO, Director | ||
| Lawrence Waldman, Independent Director | ||
| Jay Ewers, Interim CFO |
Bovie Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Bovie Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.91 | |||
| Return On Asset | -1.34 | |||
| Profit Margin | 155.90 % | |||
| Operating Margin | (3.58) % | |||
| Current Valuation | 69.68 M | |||
| Shares Outstanding | 33.2 M | |||
| Shares Owned By Insiders | 11.61 % | |||
| Shares Owned By Institutions | 42.68 % | |||
| Number Of Shares Shorted | 74.35 K | |||
| Price To Earning | 3.27 X |
Pair Trading with Bovie Medical
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bovie Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bovie Medical will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Franklin Resources could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Franklin Resources when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Franklin Resources - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Franklin Resources to buy it.
The correlation of Franklin Resources is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Franklin Resources moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Franklin Resources moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Franklin Resources can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Consideration for investing in Bovie Stock
If you are still planning to invest in Bovie Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bovie Medical's history and understand the potential risks before investing.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Stocks Directory Find actively traded stocks across global markets | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |